SMi Source Lesson Anticoagulation: Novel Oral Anticoagulants

  • SMi Source lesson Anticoagulation: Novel Oral Anticoagulants has the following microlearning topics

  • 1. Introduction

    2. Overview of Anticoagulant Agents

    3. Limitations of Traditional Rapid Acting and Traditional Oral Anticoagulants

    4. Development and Advantages of Novel Oral Anticoagulants (NOACs)

    5. Complexities of Novel Oral Anticoagulants (NOACs)

    6. Novel Oral Anticoagulants

    7. Stroke Prevention in Atrial Fibrillation (AF)

    8. Stroke Prevention in Atrial Fibrillation (AF): Guidelines

    9. Venous Thromboembolism (VTE)

    10. Administration of Novel Oral Anticoagulants: Overview

    11. Dabigatran Overview

    12. Indications

    13. aPTT, Renal Impairment, Special Considerations and Mechanism of Action

    14. Clinical Pharmacology

    15. Clinical Pharmacology: Pharmacokinetics

    16. Contraindications, Boxed Warning, and Precautions

    17. Overview: Rivaroxaban

    18. Indications, Dosage and Administration

    19. Use in Patients with Renal Impairment

    20. Clinical Pharmacology: Pharmacodynamics, Laboratory Monitoring and Anticoagulant Reversal

    21. Pharmacokinetics: Absorption

    22. Contraindications and Boxed Warning

    23. Warnings, Precautions and Use in Pregnancy

    24. Overview: Apixaban

    25. Apixaban: Dosage and Administration

    26. Apixaban: Mechanism of Action

    27. Clinical Pharmacology: Pharmacodynamics and Anticoagulant Reversal

    28. Pharmacokinetics: Absorption

    29. Drug Interaction Studies

    30. Apixaban: Contraindications and Boxed Warning

    31. Apixaban: Warnings, Precautions and Use in Pregnancy

    32. Summary of Agents